Finance

Beta
Lists
524731:BOM
Jenburkt Pharmaceuticals Ltd
₹1,140.90
-3.17%
(-37.40) 1D
Jun 19, 3:58:20 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524731...
Open
₹1,172.00
High
₹1,199.00
Low
₹1,139.00
Mkt. cap
5.04B
Avg. vol.
2.23K
Volume
3.19K
Dividend
1.81%
Quarterly dividend
₹5.18
Ex-dividend date
Aug 28, 2026
P/E ratio
14.49
52-wk high
₹1,410.00
52-wk low
₹944.00
EPS
₹78.71
Shares outstanding
4.59M
No. of employees
779
Open
₹1,172.00
High
₹1,199.00
Low
₹1,139.00
Mkt. cap
5.04B
Avg. vol.
2.23K
Volume
3.19K
Dividend
1.81%
Quarterly dividend
₹5.18
Ex-dividend date
Aug 28, 2026
P/E ratio
14.49
52-wk high
₹1,410.00
52-wk low
₹944.00
EPS
₹78.71
Shares outstanding
4.59M
No. of employees
779
News stories
From sources across the web
About Jenburkt Pharmaceuticals Ltd
CEO-
Employees779
Founded1985
Headquarters-
SectorPharmaceutical industry
Websitejenburkt.com
Last report
May 5, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
446.32M / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
355.27M
455.58M
430.24M
446.32M
Cost of goods sold
65.18M
83.56M
87.89M
86.63M
Cost of revenue
65.18M
83.56M
87.89M
86.63M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
117.21M
139.32M
147.14M
95.15M
Operating expense
207.74M
248.41M
276.38M
225.29M
Total operating expenses
272.92M
331.97M
364.27M
311.92M
Operating income
82.35M
123.60M
65.97M
134.40M
Other non operating income
20.57M
20.79M
18.15M
43.48M
EBT including unusual items
101.82M
143.32M
82.97M
137.08M
EBT excluding unusual items
101.82M
143.32M
82.97M
176.59M
Income tax expense
23.90M
41.69M
23.65M
28.59M
Effective tax rate
23.47%
29.09%
28.51%
20.85%
Other operating expenses
83.31M
101.64M
120.92M
122.05M
Net income
77.92M
101.63M
59.31M
108.50M
Net profit margin
21.93%
22.31%
13.79%
24.31%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.10M
-1.07M
-1.16M
-1.29M
Net interest expenses
-1.10M
-1.07M
-1.16M
-1.29M
Depreciation and amortization charges
7.22M
7.44M
8.32M
8.09M
EBITDA
87.49M
130.94M
71.11M
142.17M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer